Exchange: NASDAQ·Updated 04:15 AM EDT
LFST logo

LFSTLifeStance Health Group Inc

$9.80
$0.08
(0.81%)
Pre-Market
Prev Close $9.88
EarningsAug 6
Mkt Cap$3.74B
Vol51.00
News
all
press releases
ELV Accelerates Clinical Reviews Through Health OS Platform
Elevance Health's Health OS is cutting review delays and admin work, with early results showing fewer denials and holds as digital healthcare adoption expands.
Zacks
News Placeholder
More News
News Placeholder
Can Acadia's Turnaround Strategy Drive Long-Term Shareholder Value?
ACHC is shifting from expansion to returns, raising EBITDA guidance as mature facilities and rising demand support its turnaround strategy.
Zacks
News Placeholder
LifeStance Health (LFST) Upgraded to Strong Buy: Here's What You Should Know
LifeStance Health (LFST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks
News Placeholder
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare
Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare are benefiting from telehealth, AI adoption and growing home-care demand.
Zacks
News Placeholder
4 Outpatient Home Health Stocks Benefiting From Industry Trends
An aging population and rising telehealth and AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, LFST and AVAH stand to benefit.
Zacks
News Placeholder
ENSG Expands Healthcare Footprint With Iowa, California Acquisitions
With new acquisitions in California and Iowa, Ensign Group has grown its portfolio to 396 healthcare operations and 181 owned real estate properties.
Zacks
News Placeholder
Wall Street Analysts Predict a 37.26% Upside in LifeStance Health (LFST): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 37.3% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks
News Placeholder
Bears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Now
After losing some value lately, a hammer chart pattern has been formed for LifeStance Health (LFST), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Zacks
News Placeholder
SEM Expands Rehab Footprint With New Virginia Hospital Joint Venture
Select Medical and Carilion Clinic plan a 50-bed rehab hospital in Virginia as demand continues to grow.
Zacks
News Placeholder
Earnings Estimates Rising for LifeStance Health (LFST): Will It Gain?
LifeStance Health Group (LFST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks
<
1
2
...
>

Advertisement|Remove ads.